| known also as: |
C-term, Anti-ROR alpha antibody [C3] |
| known also as: |
Anti- [C3], C-term, ROR alpha |
| known also as: |
C-term, ROR alpha antibody [C3] |
| known also as: |
ROR alpha [C3] |
| known also as: |
DKFZp686M2414, MGC119326, MGC119329, NR1F1, RAR-related orphan receptor A, RAR-related orphan receptor A, ROR-alpha, ROR1, ROR2, ROR3, RORA, RZR-ALPHA, RZRA, nuclear receptor ROR-alpha, nuclear receptor RZR-alpha, nuclear receptor subfamily 1 group F member 1, retinoic acid receptor-related orphan receptor alpha, retinoid-related orphan receptor alpha, thyroid hormone nuclear receptor alpha variant 4, transcription factor RZR-alpha, Rabbit Polyclonal antibody to ROR alpha (nuclear receptor ROR-alpha) |
| Other names: |
Nuclear receptor ROR-alpha, Nuclear receptor RZR-alpha, Nuclear receptor subfamily 1 group F member 1, RAR-related orphan receptor A, Retinoid-related orphan receptor-alpha, nuclear receptor ROR-alpha, nuclear receptor RZR-alpha, nuclear receptor subfamily 1 group F member 1, retinoic acid receptor-related orphan receptor alpha, retinoid-related orphan receptor alpha, thyroid hormone nuclear receptor alpha variant 4, transcription factor RZR-alpha, nuclear receptor ROR-alpha isoform c |
| Gene name: |
ROR alpha |
| Other gene names: |
NR1F1, NR1F1, ROR1, ROR2, ROR3, RORA, RZR-ALPHA, RZRA, RZRA, RORA |
| Category: |
Antibodies |
| Clonality: |
Polyclonal |
| Immunoglobulin isotype: |
IgG |
| Clone: |
Polyclonal antibody |
| Host organism: |
Rabbit |
| Species reactivity: |
Mouse, Human |
| Purification method: |
Purified by antigen-affinity chromatography |
| Form/Appearance: |
Liquid |
| Concentration: |
1 miligram per 1 mililiter |
| Storage and shipping: |
Aliquot and store at -20 degrees Celsius, Multiple freeze-thaw cycles should be avoided as they may damage the peptide chains and/or other components and reduce the activity, The product should be kept as concentrated solution |
| Tested for:: |
Western Blot (WB) |
| Description: |
Polyclonal antibodies generally are more stable and retain their reactivity under unfavorable conditions, Polyclonal antibodies have series of advantages - larger batches can be supplied at a time, Properly used, To obtain more detailed information on productone, please, refer to the full product datasheet, the time needed for production is considerably shorter, they are inexpensive to manufacture and respectively to buy, this antibody will ensure excellent and reproducible results with guaranteed success for the applications that it is tested in, productone is a polyclonal antibody of high purity and binding affinity for the antigen that it is risen against |
| Advisory: |
For antibodies that are in liquid form or reconstituted lyophilized antibodies small amounts could become entrapped on the seal or the walls of the tube, Prior to use briefly centrifuge the vial to gather all the solution on the bottom, avoid cycles of freezing and thawing, please, In order to retain the quality and the affinity of productone unchanged |
| French translation: |
anticorps |
| Gene target: |
ROR alpha [C3] C-term |
| Short name: |
ROR alpha antibody [C3] C-term |
| Alternative name: |
c terminus, ROR a (Antibody to) [complement component 3] |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
AHUS5 and ARMD9 and ASP and C3a and C3b and CPAMD1 and HEL-S-62p, BT, C3 and IDBG-193788 and ENSMUSG00000024164 and 102642251, C3 and IDBG-21798 and ENSG00000125730 and 718, C5L2 anaphylatoxin chemotactic receptor binding, Extracellular, alternative pathway and biological process this GO :0006958 and complement activation, classical pathway and biological process this GO :0007165 and signal transduction and biological process this GO :0007186 and G-protein coupled receptor signaling pathway and biological process this GO :0010575 and positive regulation vascular endothelial growth factor production and biological process this GO :0010828 and positive regulation of glucose transport and biological process this GO :0010866 and regulation of triglyceride biosynthetic process and biological process this GO :0010884 and positive regulation of lipid storage and biological process this GO :0010951 and negative regulation of endopeptidase activity and biological process this GO :0030449 and regulation of complement activation and biological process this GO :0031715 and C5L2 anaphylatoxin chemotactic receptor binding and molecular function this GO :0045087 and innate immune response and biological process this GO :0045745 and positive regulation of G-protein coupled receptor protein signaling pathway and biological process this GO :0045766 and positive regulation of angiogenesis and biological process this GO :0050766 and positive regulation of pha this GO cytosis and biological process this GO :0050776 and regulation of immune response and biological process this GO :0070062 and extracellular vesicular exosome and cellular component this GO :0072562 and blood microparticle and cellular component this GO :2000427 and positive regulation of apoptotic cell clearance and biological process, this GO :0001798 and positive regulation of type IIa hypersensitivity and biological process this GO :0001934 and positive regulation of protein phosphorylation and biological process this GO :0001970 and positive regulation of activation of membrane attack complex and biological process this GO :0004866 and endopeptidase inhibitor activity and molecular function this GO :0005102 and receptor binding and molecular function this GO :0005515 and protein binding and molecular function this GO :0005576 and extracellular region and cellular component this GO :0005615 and extracellular space and cellular component this GO :0005886 and plasma membrane and cellular component this GO :0006631 and fatty acid metabolic process and biological process this GO :0006954 and inflammatory response and biological process this GO :0006955 and immune response and biological process this GO :0006956 and complement activation and biological process this GO :0006957 and complement activation, this GO :0004866 : endopeptidase inhibitor activity, this GO :0004866 : endopeptidase inhibitor activity and also this GO :0005102 : receptor binding and also this GO :0005515 : protein binding and also this GO :0031715 : C5L2 anaphylatoxin chemotactic receptor binding, this GO :0005102 : receptor binding, this GO :0005515 : protein binding, this GO :0031715 : C5L2 anaphylatoxin chemotactic receptor binding, 12266, 19562 and IDBG-643930 and ENSBTAG00000017280 and 280677, complement component 3 |
| Identity: |
43773 |
| Gene: |
LINC-ROR |
More about : LINC-ROR |
| Long gene name: |
long intergenic non-protein coding RNA, regulator of reprogramming |
| Synonyms: |
lincRNA-RoR lincRNA-ST8SIA3 ROR |
| Locus: |
18q21, 31 |
| Discovery year: |
2012-05-01 |
| GenBank acession: |
HQ315778 |
| Entrez gene record: |
100885779 |
| Pubmed identfication: |
21057500 23208419 23541921 23597480 24463816 |
| RefSeq identity: |
NR_048536 |
| Classification: |
Long non-coding RNAs Competing endogenous long non-coding RNAs |
| Havana BLAST/BLAT: |
OTTHUMG00000171587 |